Joined April 2021
- Tweets 36
- Following 62
- Followers 162
- Likes 8
1 Photos and videos
Dominik Paul Modest retweeted
12 Aug 2025
Health-related quality of life in patients with KRASG12C-mutated chemo... sciencedirect.com/science/ar…
1
2
255
Dominik Paul Modest retweeted
3 Jun 2024
🚨 #LowerGIcancer highlights from #ASCO24 🚨
Prof. @JenSeligmann & Dr @ModestDominik share their views on new data from #COLLISION & #TRANSMET trials presented at the congress.
⬇️🎥⬇️
#MedEd #ASCOhighlights #CRCSM #LowerGI
8
27
539,589
Dominik Paul Modest retweeted
4 Jun 2024
🚨#LowerGIcancer highlights from #ASCO24🚨
Medical oncologists Prof. @JenSeligmann and Dr @ModestDominik share their views on new data in #rectalcancer and #CRC from the NEOPRISM-CRC trial & LBA3512.
Watch the video 📺 👇
#MedEd #oncology #CRCSM
1
13
40
535,091
Dominik Paul Modest retweeted
29 May 2024
Voting open for @myESMO #president 2027-2028! Vote now, or on your way to #ASCO24! My vote 👇 @Prof_Nadia_H #mentor #strong #womenleaders #femalepresident
16
30
9,406
Original Article: Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C (CodeBreaK 300 phase 3 trial) nej.md/3M8Qw3k
#ESMO23 #oncology
ALT Progression-free Survival as Assessed by Blinded Independent Central Review (Intention-to-Treat Population)
1
35
102
45,854
Dominik Paul Modest retweeted
6 Oct 2022
Five @giconnectInfo experts provide a handy update from #ESMO2022!
➡️ Podcast Ep. 1: Lower #GIcancer highlights
➡️ Podcast Ep. 2: Upper #GIcancer highlights
➡️ Video summary of NICHE-2 trial
For the podcasts, video and downloadable content, follow: ow.ly/6GQF50L2EhI
#MedEd
3
7
Dominik Paul Modest retweeted
11 Sep 2022
💥💥💥💥@MyriamChalabi #ESMO22 discussing NICHE2 - neoadjuvant nivo/ipi in locally advanced colon cancer
💥short duration safe pre-op
💥4% grade 3 events
💥100% R0 resection
💥95% major path; 67% pCR
…round of applause in session!
1/2
5
51
145
11 Sep 2022
Niche-2. No need for further interpretation… congrats to Myriam!! What a perfect presentation of a super trial. Great that we had a wowww moment in colon cancer.
6
23
11 Sep 2022
Great to see randomized data. Congratulations!! Great achievement. Final conclusion (do it or not) more complex. Data suggest that HIPEC influences local but not systemic control and systemic relapse is a frequent issue.
11 Sep 2022
HIPECT4 shows that HIPEC with MMC in effective and safe to prevent peritoneal relapse in T4 colorectal cancer, presented in @myESMO 2022. @AndreaCercek @PSOGI_EC @ESSOnews @aecirujanos @_SEOM @indepso @ISSPP1 @HUReinaSofia @IMIBIC @SeguraJuanJ @operarelcancer @GECOP_ @PSugarbaker
1
4
11
Dominik Paul Modest retweeted
7 Jun 2022
7 Jun 2022
Late check-out and ready to fly back home🇮🇹! This has been an incredible ASCO for science, meeting new and old friends, discussing projects and also..so much laughing ! @ChiaraCrem1 @lonardi_sara @MyriamChalabi @BenWestphalen @JenSeligmann @ModestDominik @darioT_ @PTarantinoMD
1
2
Dominik Paul Modest retweeted
4 Jun 2022
Proud to present our subgroup analysis of the PANAMA-study according to #gender and age in patients with #colorectalcancer at #ASCO2022! Thanks to my amazing mentors @ModestDominik and @StintzingS for their support!
6
21
Dominik Paul Modest retweeted
5 Apr 2022
The protocol of the PORT trial is published, which aims to generate evidence that post-resection/ablation/radiation chemotherapy improves the survival in patients with metastatic colorectal cancer.
bmccancer.biomedcentral.com/…
@ModestDominik
@Sauer_et_al
1
5
8
Dominik Paul Modest retweeted
18 Nov 2021
Our new podcast series is out! In Episode 2 @JenSeligmann, @McreeAutumn and @ModestDominik are discussing #immunotherapy approaches! Listen to the podcast and download the transcript at: ow.ly/erC950GKbN6
#MedEd #GI #GC
1
1
Dominik Paul Modest retweeted
Eine interdisziplinäre klinische Studie zur Therapie von #Darmkrebs startet nun unter Leitung der #CharitéBerlin. Die FIRE-9/PORT-Studie soll helfen, die Neuentstehung von Metastasen zu verhindern. @ModestDominik @StintzingS @AIO_Onkologie @LMU_Uniklinikum charite.de/service/pressemit…
1
6
13
Dominik Paul Modest retweeted
10 Jun 2021
Adding panitumumab to 5-FU and leucovorin significantly improved PFS compared with 5-FU/leucovorin alone as a maintenance therapy for patients with RAS wild-type metastatic CRC. #ASCO21 | @ModestDominik
cancernetwork.com/view/maint…
1
Dominik Paul Modest retweeted
7 Jun 2021
You guessed it... having an opinion is not knowing it. 😉
1
2
4
Dominik Paul Modest retweeted
13 Nov 2020
Good job @ArndtStahler !
2
4
Dominik Paul Modest retweeted
7 Jun 2021
We spoke w/ @StintzingS of @ChariteBerlin on findings of the Phase II FIRE-4.5
Watch here ➡️ow.ly/YBSM50F4Q5Y
@VJOncology @ASCO #ASCO21 @OncoAlert #ColorectalCancer #CRCsm #CRC #GIsm
5
4
Dominik Paul Modest retweeted
7 Jun 2021
On behalf of myself and @GIcancerDoc, we would like to 🙏our amazing #colorectal #cancer #asco21 track leader, @AndreaCercek for organizing these abstracts for our session!
And thank YOU to ALL the participants that sent in GREAT questions!! 💙 #CancerResearch #clinicaltrials
3
5
54